About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Preclinical Validation of New Anti-melanoma Compounds

NCT03798977·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Centre Hospitalier Universitaire de Nice

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient with metastatic melanoma
Not opposition of the patient will have been looked for

You may not be if

Primary resistance,
Absence of resistance,
Patient already included in other trials

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedFeb 2018

UpdatedFeb 6, 2024

Conditions

Where1

Nice hospital
Nice, France

Clareo Health | Preclinical Validation of New Anti-melanoma Compounds